Literature DB >> 16696362

Outcomes of primary and secondary tracheoesophageal puncture: a 16-year retrospective analysis.

Elaine Cheng1, Margie Ho, Cindy Ganz, Ashok Shaha, Jay O Boyle, Bhuvanesh Singh, Richard J Wong, Snehal Patel, Jatin Shah, Ryan C Branski, Dennis H Kraus.   

Abstract

The current study retrospectively reviewed the cases of 68 patients who had undergone total laryngectomy and tracheoesophageal puncture (TEP) over a 16-year period. Fifty-one patients underwent primary TEP and 17 underwent secondary TEP. Nearly 80% of patients who received TEP at the time of laryngectomy achieved excellent voice quality perceptually. In contrast, only 50% of secondary TEP patients achieved excellent voice ratings. This difference was statistically robust (p = 0.03). Although both surgical and prosthesis-related complications occurred more frequently following primary TEP, statistically significant differences were not achieved. Neither pre- nor postoperative radiotherapy had any effect on voice restoration or complication rates. Based on these data, primary TEP may be preferable for several reasons, including a greater likelihood of successful voice restoration, a shorter duration of postoperative aphonia, and the elimination of the need for a second operation and interim tube feedings.

Entities:  

Mesh:

Year:  2006        PMID: 16696362

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  8 in total

1.  Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.

Authors:  Sarah A Gitomer; Katherine A Hutcheson; Brandon L Christianson; Madeleine B Samuelson; Denise A Barringer; Dianna B Roberts; Amy C Hessel; Randal S Weber; Jan S Lewin; Mark E Zafereo
Journal:  Head Neck       Date:  2016-07-09       Impact factor: 3.147

2.  Long-term results with tracheoesophageal voice prosthesis: primary versus secondary TEP.

Authors:  Paolo Boscolo-Rizzo; Federica Zanetti; Silvia Carpené; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-23       Impact factor: 2.503

3.  Secondary tracheoesophageal puncture with in-office transnasal esophagoscopy.

Authors:  Brad LeBert; Andrew J McWhorter; Melda Kunduk; Rohan R Walvekar; Jan S Lewin; Katherine A Hutcheson; Denise A Barringer; Amy C Hessel; F Christopher Holsinger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-12

4.  Analysis of Factors Affecting the Longevity of Voice Prosthesis Following Total Laryngectomy with a Review of Literature.

Authors:  Arvind Krishnamurthy; Suhaildeen Khwajamohiuddin
Journal:  Indian J Surg Oncol       Date:  2017-09-06

5.  Tracheo Esophageal Prosthesis Insertion Under Endoscopic Guidance and Local Anaesthesia- Feasibility and Outcome.

Authors:  Sajith Babu Thavarool; Sandeep Vijay; Manu S; Naveen George; Raveena R Nair
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-10-03

Review 6.  Post-laryngectomy voice rehabilitation with voice prosthesis: 15 years experience of the ENT Clinic of University of Catania. Retrospective data analysis and literature review.

Authors:  A Serra; P Di Mauro; D Spataro; L Maiolino; S Cocuzza
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

7.  Do salivary bypass tubes lower the incidence of pharyngocutaneous fistula following total laryngectomy? A retrospective analysis of predictive factors using multivariate analysis.

Authors:  Robert W A Hone; Eqramur Rahman; Gentle Wong; Yvette Annan; Victoria Alexander; Ali Al-Lami; Kiran Varadharajan; Michael Parker; Ricard Simo; Lisa Pitkin; Alasdair Mace; Enyinnaya Ofo; Alistair Balfour; Iain J Nixon
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-23       Impact factor: 2.503

8.  Multivariate analysis of risk factors for pharyngocutaneous fistula after total laryngectomy.

Authors:  Paolo Boscolo-Rizzo; Giuseppe De Cillis; Carlo Marchiori; Silvia Carpenè; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 3.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.